Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: 18F‑Florbetaben (Neuraceq®) PET/MRI Evaluation of Cardiac Amyloid
Brief Summary: Cardiac amyloidosis is a disorder characterized by the deposition of abnormal proteins called amyloid in the heart tissue. This makes it difficult for the heart to function properly. The investigators wish to evaluate if the radiopharmaceutical 18F‑Florbetaben (Neuraceq®) that targets beta amyloid can also identify cardiac amyloid deposition.